CT
Cirius Therapeutics, Inc.
SEC filingBiotechnology · Grand Rapids, MI
Amount raised$800Ksold at filing
Total offering$1.2M$400K still open
Investors in the raise22count reported to the SEC
FiledOct 8, 2025first sale Oct 7, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Michael A JandernoaDirector
Robert A BeardsleyExecutive Officer
Robert A ZerbeDirector
David A Van AndelDirector
Jerry A CallahanExecutive Officer
Executive officers, directors and promoters as listed on the Form D.